Sammanfattning Metformin r ett centralt och vlstuderat lkemedel vid behandling av typ 2-diabetes, men det r varken utvecklat eller godknt som behandling fr viktnedgng
Whilst often discussed alongside GLP-1 receptor agonists such as semaglutide and liraglutide, Mounjaro is technically a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
The most practical GLP-1 must-haves for beginners are a water bottle, easy protein options, a sharps container if injections are part of your routine, alcohol prep pads, a medication travel case if needed, a progress-tracking method, and a place to record symptoms and provider questions
Abstract Purpose of Review The glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) liraglutide and semaglutide, and the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) RA tirzepatide are approved for the treatment of overweight and obesity